Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
29 hedge funds and large institutions have $8.33M invested in Vyant Bio, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
6% less funds holding
Funds holding: 31 → 29 (-2)
21% less capital invested
Capital invested by funds: $10.5M → $8.33M (-$2.18M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$873K |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$789K |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$163K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$47.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.12M |
| 2 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$434K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$167K |
| 4 |
DM
Diker Management
New York
|
-$94.7K |
| 5 |
Millennium Management
New York
|
-$94K |
VYNT Hedge Fund Activity: Q1 2015 in Review
29 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2015, worth a combined $8.33M — down 21% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VYNT and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Granite Investment Partners, opening a new position worth an estimated $873K. The largest seller was Bank of Montreal, exiting entirely with an estimated $4.12M sold.
- 29 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2015, down from 31 in Q4 2014.
- Funds reported $8.33M of Vyant Bio, Inc. Common Stock stock for Q1 2015, down 21% quarter-over-quarter.
- 5 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2015 and 7 closed out, a net change of -2 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q1 2015 was Granite Investment Partners, an estimated $873K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q1 2015 was Bank of Montreal, an estimated $4.12M sold.
Based on aggregated 13F filings for Q1 2015.